Testosterone Replacement Therapy Guidelines
Introduction to Testosterone Replacement Therapy
- Testosterone gel is recommended as the initial treatment for testosterone replacement therapy over injections due to more stable serum testosterone levels and lower risk of cardiovascular events and erythrocytosis 1
Comparison of Formulations
- Testosterone gel provides more stable day-to-day testosterone levels without the peaks and valleys seen with injections 1
- Testosterone gel is available as 1% and 1.62% formulations with typical dosing of 50-100 mg/day 2
- Testosterone injections are available as testosterone cypionate or enanthate at 100-200 mg every 2 weeks or 50 mg weekly 2
Safety Considerations
- The FDA required labeling changes in 2015 to inform about possible increased risk of heart attack and stroke with testosterone preparations 1
- Evidence suggests testosterone injections are associated with greater risk of cardiovascular events, hospitalizations, and deaths compared to gels 1, 2
- Injections are associated with significantly higher risk of erythrocytosis than topical preparations 3, 4
- Erythrocytosis with injections is associated with supraphysiologic levels of bioavailable testosterone 3
Monitoring Recommendations
- Monitor testosterone levels 2-3 months after treatment initiation and after any dose change 1
- Once stable levels are confirmed, monitoring every 6-12 months is typically sufficient 1
- Monitor hematocrit/hemoglobin and PSA levels regularly 5
- For injections: measure testosterone levels midway between injections, targeting mid-normal values 1
- For gels: levels can be measured at any time, understanding that peak values occur 6-8 hours after application 1
Clinical Decision Algorithm
- Best for patients concerned about stable hormone levels and minimizing cardiovascular risk 1, 2
- Consider if patient has history of or risk factors for cardiovascular disease 1
- Weekly rather than biweekly injections if using injectable form provides more stable serum testosterone levels and reduces time spent in supratherapeutic and subtherapeutic ranges 1, 5